The pan-PPAR agonist lanifibranor decreases portal pressure in models of both hepatic and prehepatic portal hypertension
Authors:
- Anneleen HeldensAHAnneleen Heldens
- Christophe CasteleynCCChristophe Casteleyn
- Louis OnghenaLOLouis Onghena
- Milton AntwiMAMilton Antwi
- Benedicte DescampsBDBenedicte Descamps
- Christian VanhoveCVChristian Vanhove
- Xavier VerhelstXVXavier Verhelst
- Hans Van VlierbergheHVHans Van Vlierberghe
- Lindsey DevisscherLindsey Devisscher
- Jean-Louis JunienJJJean-Louis Junien
- Anja GeertsAGAnja Geerts
- Guillaume WettsteinGWGuillaume Wettstein
- 20 July 2023
- journal article
- abstracts
- Published by Elsevier in Journal of Hepatology
- Vol. 78, S226-S227